NovaBay Pharmaceuticals, Inc. 3Y Total Assets Growth (CAGR)

3Y Total Assets Growth (CAGR) of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including 3Y Total Assets Growth (CAGR) growth rates and interactive chart.


Highlights and Quick Summary

  • Annual 3Y Total Assets Growth (CAGR) for 2021 was 36.82% (a -46.27% decrease from previous year)
  • Annual 3Y Total Assets Growth (CAGR) for 2020 was 68.53% (a -786.67% decrease from previous year)
  • Annual 3Y Total Assets Growth (CAGR) for 2019 was -9.98% (a -144.12% decrease from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical 3Y Total Assets Growth (CAGR) of NovaBay Pharmaceuticals, Inc.

Most recent 3Y Total Assets Growth (CAGR)of NBY including historical data for past 10 years.

Interactive Chart of 3Y Total Assets Growth (CAGR) of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. 3Y Total Assets Growth (CAGR) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 36.82%
2020 68.53%
2019 -9.98%
2018 22.62%
2017 10.17%
2016 -0.58%
2015 -35.85%
2014 -22.13%
2013 0.29%
2012 55.89%
2011 28.42%

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology